Cytek Biosciences, Inc. CTKB 深 沪
等待开盘 07-06 09:30:00 美东时间
4.59
+0.010
+0.22%
华盛通- 最 高4.68
- 今 开4.58
- 成交量 88.98万股
- 最 低 4.535
- 昨 收 4.58
- 总市值 5.93亿
- 52周最高 6.18
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 3.09
- 委 比 -37.38%
- 总股本 1.29亿
- 历史最高 28.70
- 量 比 0.54
- 振 幅 3.17%
- 历史最低 2.37
- 每 手 1
- 风险率 0.60%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session
US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market. Other stocks moving in pre-market.
06-05 20:05
Braze Posts Mixed Q1 Results, Joins Sidus Space, Everpure And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixed Q1 results. Other stocks also down.
05-28 20:01
美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
05-14 14:32
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Cytek Biosciences shares are trading lower after the company reported worse-than-expected Q1 EPS results.
Cytek Biosciences shares are trading lower after the company reported worse-tha...
05-08 05:19
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Cytek Sees $62M Q4 Revenue, Forecasts About $201M in Full-Year 2025 Sales
Cytek Biosciences, Inc. (NASDAQ:CTKB), a leading cell analysis solutions company, today announced preliminary, unaudited revenue results for the fourth quarter and full year ended December 31, 2025.Cytek expects its
01-12 18:08
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
TD Cowen Maintains Buy on Cytek Biosciences, Raises Price Target to $5
TD Cowen analyst Brendan Smith maintains Cytek Biosciences (NASDAQ:CTKB) with a Buy and raises the price target from $4 to $5.
01-09 02:16
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 500 points o...
2025-11-14 22:54
